fbpx

Do you have

Low Back Pain?

Learn about a no-cost, new investigational procedure to potentially treat symptoms of low back pain caused by Chronic Lumbar Disc Disease (cLDD).

ARE YOU ELIGIBLE?

Do you struggle with

LOW BACK PAIN?

Low back pain is a common condition that affects over 80% of Americans during their lifetime. It is also the leading cause of disability among Americans between 45 and 65 years of age1. Abnormalities in the body’s structure can lead to low back pain, with changes in the intervertebral discs accounting for about 40% of chronic low back pain cases.

Chronic Lumbar Disc Disease (cLDD) affects the intervertebral discs in the spine and can be caused by factors such as age, genetics, injury, or overuse. Its symptoms include back pain, stiffness, and reduced mobility, significantly impacting quality of life. Treatment for cLDD varies based on symptoms and aims to reduce pain, improve function, and prevent further deterioration.

If you have tried available treatments for Chronic Lumbar Disc Disease (cLDD) but still experience chronic low back pain, you may qualify for a new research study, now offered at select U.S. centers. The study will investigate the use of a single injection of stem cells into the disc to alleviate the symptoms of Chronic Lumbar Disc Disease (cLDD). If you qualify and choose to participate, you will receive all study-related care at no cost.

ARE YOU ELIGIBLE?

FILL OUT THE FORM BELOW IF YOU MEET THE FOLLOWING CRITERIA

  • Are 18 to 60 years of age
  • Have had low back pain for at least 6 months
  • Have not had lumbosacral spine surgery
  • Are not pregnant or breastfeeding
  • Have not used nicotine products in the last 3 months
ARE YOU ELIGIBLE?

About the Study

Chronic Lumbar Disc Disease (cLDD) can cause symptoms of chronic lower back pain, radiating pain, stiffness, and reduced mobility, impacting an individual’s daily activities and ability to work. Common treatments for chronic back pain, such as physical therapy, massage, acupuncture, chiropractic care, steroid injections, analgesics, and anti-inflammatories, may not be effective long-term treatments for many patients.

This clinical trial will study the safety and efficacy of a single stem cell injection into the lumbar disc area using the stem cells obtained from your blood and bone marrow. Stem cells have anti-inflammatory and reparative properties that may help to regenerate the disc environment. The study will take approximately 26 months, with treatment and early assessments taking place in the first six months, followed by check-ups at one year and two years after treatment.

The study includes trial-related medical examinations, surveys, laboratory work, MRIs, X-rays, and assessments by medical investigators. There will be no cost for participating in the trial, and participants may receive compensation for transportation and the time required to participate.

ARE YOU ELIGIBLE?

Why participate?

If you’re struggling with Chronic Low Back Pain, and conservative treatments have failed to alleviate your discomfort, you may qualify for a new research study, now being offered at select centers throughout the U.S. The study is for a single injection into the disc of an investigational treatment designed to relieve symptoms caused by Chronic Lumbar Disc Disease (cLDD).

No-cost Study Care

You will receive study-related care from experienced doctors, nurses, and research staff.

Exams

The study will include physical examinations, surveys, laboratory work, MRIs, X-rays, and other examination visits with a trained investigator.

Compensation

You might be eligible to receive compensation for your time and travel.

ARE YOU ELIGIBLE?

Chat With a Research Coordinator

Fill out the form below, and you will be advised if you are eligible. If you meet the initial screening criteria, you will be contacted by someone from a research location near you. If you do not meet the minimum criteria, still submit the form. The study criteria can change in the future, and you might become eligible later.

1 Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet. 2016 Nov 26;388(10060):2665- 712.

© 2024 Accelerate Recruitment | Privacy Policy | Legal Notice